New scan aims to spot breast cancer more accurately
NCT ID NCT07180433
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study will test a new type of PET/MRI scan that uses a radioactive tracer called 18F-FAPI to see if it can detect breast cancer more accurately than current methods. The researchers will enroll 60 women with breast cancer at various stages. The goal is to see how well this scan finds tumors, lymph node spread, and recurrences compared to standard imaging and lab results.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
Active substance
18F-FAPI (a radioactive tracer)
What this could lead to
If successful, this could lead to more precise breast cancer diagnosis, better treatment planning, and less overtreatment.
What could go wrong
This is a small, early pilot study (60 participants) testing a new imaging technique. It may not prove better than existing methods, and results may not apply to all patients.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for BREAST CANCER are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.